Angiocrine Bioscience in New York, NY is a pioneering company dedicated to utilizing E-CEL Therapies to positively impact patients' lives through the reparative powers of cellular therapies. Their cutting-edge science and research have led to numerous publications, showcasing their commitment to advancing the field of regenerative medicine.
With a strong executive leadership team, board of directors, and scientific advisory board, Angiocrine Bioscience is at the forefront of developing innovative solutions for various medical conditions. Their focus on restoring health and improving patient outcomes underscores their mission to harness the potential of cellular therapies for the betterment of healthcare.
Generated from the website